These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 15668072)

  • 1. The use of risperidone among individuals with mental retardation: clinically supported or not?
    Singh AN; Matson JL; Cooper CL; Dixon D; Sturmey P
    Res Dev Disabil; 2005; 26(3):203-18. PubMed ID: 15668072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituting traditional antipsychotics with risperidone for individuals with mental retardation.
    Simon EW; Blubaugh KM; Pippidis M
    Ment Retard; 1996 Dec; 34(6):359-66. PubMed ID: 8990820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: an overview.
    Matson JL; Neal D
    Res Dev Disabil; 2009; 30(3):572-86. PubMed ID: 18845418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of psychotropic medication among individuals with mental retardation].
    Baasland G; Engedal K
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1751-3. PubMed ID: 19756056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of clozapine among individuals with intellectual disability: a review.
    Singh AN; Matson JL; Hill BD; Pella RD; Cooper CL; Adkins AD
    Res Dev Disabil; 2010; 31(6):1135-41. PubMed ID: 20692809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.
    Holden B; Gitlesen JP
    Res Dev Disabil; 2004; 25(6):509-21. PubMed ID: 15541629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychotropic medicines to patients with mental retardation].
    Bygdnes AM; Kristiansen A
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1028-30. PubMed ID: 17457386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with reduction in antipsychotic medication dosage in adults with mental retardation.
    Luchins DJ; Dojka DM; Hanrahan P
    Am J Ment Retard; 1993 Jul; 98(1):165-72. PubMed ID: 8103998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational use and rationale for use: psychiatric medication at an Argentine institution for intellectual disability.
    de Menil V; Cohen A
    Transcult Psychiatry; 2009 Dec; 46(4):651-71. PubMed ID: 20028682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical guidelines for the use of new generation antipsychotic drugs (except clozapine) in adult individuals with intellectual disabilities.
    de Leon J; Greenlee B; Barber J; Sabaawi M; Singh NN
    Res Dev Disabil; 2009; 30(4):613-69. PubMed ID: 19084370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric illness in mental retardation: an update on pharmacotherapy.
    Masi G; Luccherino L
    Panminerva Med; 1997 Dec; 39(4):299-304. PubMed ID: 9478071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practitioner review: Psychopharmacology in children and adolescents with mental retardation.
    Handen BL; Gilchrist R
    J Child Psychol Psychiatry; 2006 Sep; 47(9):871-82. PubMed ID: 16930381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
    Sankaranarayanan J; Puumala SE
    Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance.
    Lott RS; Kerrick JM; Cohen SA
    Psychopharmacol Bull; 1996; 32(4):721-9. PubMed ID: 8993095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of prescription of four major antipsychotics: a retrospective study based on medical records of psychiatric inpatients.
    Gasquet I; Gury C; Tcherny-Lessenot S; Quesnot A; Gaudebout P
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):805-11. PubMed ID: 16015580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic medication for behaviour problems in people with intellectual disability: a review of the current literature.
    Deb S; Unwin GL
    Curr Opin Psychiatry; 2007 Sep; 20(5):461-6. PubMed ID: 17762588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of psychotropic medication in Oklahoma: a statewide survey.
    Spreat S; Conroy JW; Jones JC
    Am J Ment Retard; 1997 Jul; 102(1):80-5. PubMed ID: 9241410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.